← Back to Search

Equity Dashboard and Population Health Coordinator Support for High Blood Pressure

N/A
Waitlist Available
Led By Andrew S Hwang, MD/MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test whether giving doctors information about their patients' outcomes, sorted by race and language, will help those doctors improve care forBlack, Indigenous and People of Color (BIPOC) and patients with limited English proficiency (LEP).

Eligible Conditions
  • High Blood Pressure
  • Diabetes
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hypertension control
Secondary outcome measures
Breast cancer screening rates
Hemoglobin A1c control

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Equity Dashboard, Population Health Coordinator and Community Health Worker SupportExperimental Treatment1 Intervention
After the step in which the primary care providers are randomized to receiving intervention, one group of providers will receive the equity dashboard data and complete an equity huddle where they will review their list of eligible patients (Black, Indigenous and People of Color [BIPOC] patients and patients with limited English proficiency [LEP]) with a population health coordinator (PHC). The goal of the equity huddle will be to develop a plan to improve eligible patients' hypertension control. One of the options will be to refer patients to a community health worker (CHW) program focused specifically on addressing hypertension.
Group II: Equity Dashboard and Population Health Coordinator SupportExperimental Treatment1 Intervention
After the step in which the primary care providers are randomized to receiving intervention, a second group of providers will receive the equity dashboard data and complete an equity huddle where they will review their list of eligible patients (Black, Indigenous and People of Color [BIPOC] patients and patients with limited English proficiency [LEP]) with a population health coordinator (PHC). The goal of the equity huddle will be to develop a plan to improve eligible patients' hypertension control.
Group III: Delayed interventionActive Control1 Intervention
Black, Indigenous and People of Color (BIPOC) patients and patients with limited English proficiency (LEP) before their primary care providers are randomized to receiving the intervention. (By the end of the 12 steps, all BIPOC/LEP patients will be assigned to an experimental group)
Group IV: Usual CareActive Control1 Intervention
Patients who are not eligible for additional clinical support (i.e. White and English speaking patients).

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,187,539 Total Patients Enrolled
Andrew S Hwang, MD/MPHPrincipal InvestigatorMGH

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age limitation for this medical experimentation extend beyond 60?

"Participants hoping to be included in this medical trial must fall between the age brackets of 18 and 85. For those younger than 18, there are 124 trials available and for patients aged 65 or beyond, 2113 studies can offer aid."

Answered by AI

How many participants are being accepted to join this research project?

"Affirmative. According to the clinicaltrials.gov, this trial has been open since March 24th 2022 and is still actively seeking subjects for participation. 3600 individuals are being invited to join at one site location."

Answered by AI

Are recruitment efforts still underway for this investigation?

"Data hosted on clinicaltrials.gov reveals that this experiment, first initiated on March 24th 2022 is currently recruiting patients for participation. The trial was last edited on May 3rd of the same year."

Answered by AI

May I participate in this investigation?

"In order to join this clinical trial, potential participants should have a diagnosis of hypertension and be between 18-85 years old. Currently, the study is looking for around 3600 enrollees."

Answered by AI
~3492 spots leftby Apr 2025